In vitro fluorescence displacement investigation of thyroxine transport disruption by bisphenol A

Journal of Environmental Sciences

Volumn 23, Issue 2, 2011, Pages 315-321

  Cao, Jie ^a   Guo, Liang Hong ^a   Wan, Bin ^a   Wei, Yin ^a  

^a RESEARCH CENTER FOR ECO ENVIRONMENTAL SCIENCES   (China)

Author keywords

Bisphenol A; Fluorescence displacement method; Human serum albumin; Human thyroxine binding globulin; Human transthyretin

Indexed keywords

BINDING AFFINITIES; BINDING CONSTANT; BINDING INTERACTION; BISPHENOL A; COMPETITIVE BINDING; DANSYLAMIDE; ENDOCRINE DISRUPTOR; FLUORESCENCE MEASUREMENTS; FLUORESCENCE PROBES; HIGH PRODUCTION VOLUMES; HUMAN PLASMAS; HUMAN SERUM ALBUMIN; HUMAN SERUM ALBUMINS; HUMAN THYROXINE-BINDING GLOBULIN; HUMAN TRANSTHYRETIN; IN-VITRO; INTRINSIC FLUORESCENCE; L-PROLINE; SITE-SPECIFIC; STRUCTURAL SIMILARITY; THYROID HORMONES; TRANSPORT PROTEINS; TRANSTHYRETIN;

AMINO ACIDS; BINDING ENERGY; BODY FLUIDS; HORMONES; PHENOLS; PLASMA (HUMAN); PROBES; PROTEINS; TOXICITY;

FLUORESCENCE;

4,4' ISOPROPYLIDENEDIPHENOL; ENDOCRINE DISRUPTOR; FLUORESCENT DYE; LIOTHYRONINE; PHENOL DERIVATIVE; THYROXINE;

DRUG; ENDOCRINE DISRUPTOR; FLUORESCENCE; HORMONE; PLASMA; PROTEIN; SERUM; TOXICITY;

ARTICLE; BLOOD; HUMAN; METABOLISM; TRANSPORT AT THE CELLULAR LEVEL;

BIOLOGICAL TRANSPORT; ENDOCRINE DISRUPTORS; FLUORESCENT DYES; HUMANS; PHENOLS; THYROXINE; TRIIODOTHYRONINE;

EID: 79551672979     PISSN: 10010742     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1001-0742(10)60408-1     Document Type: Article

References (34)

1. Cao J, Lin Y, Guo LH, Zhang AQ, Wei Y, Yang Y Structure-based investigation on the binding interaction of hydroxylated polybrominated diphenyl ethers with thyroxine transport proteins. Toxicology 2010, 277(1-3):20-28.
2. Chen YM, Guo LH Combined fluorescence and electrochemical investigation on the binding interaction between organic acid and human serum albumin. Journal of Environmental Sciences 2009, 21(3):373-379.
3. Cheng SY, Pages RA, Saroff HA, Edelhoch H, Robbins J Analysis of thyroid hormone binding to human serum prealbumin by 8-anilinonaphthalene-1-sulfonate fluorescence. Biochemistry 1977, 16(16):3707-3713.
4. 50) of an enzymatic reaction. Biochemical Pharmacology 1973, 22:3099-3108.
5. Cody V, Hazel J Molecular conformation of ammonium 8-anilino-1-naphthalenesulfonate hemihydrate: a fluorescent probe for thyroxine binding to thyroxine binding globulin. Journal of Medicinal Chemistry 1977, 20(1):12-17.
6. Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, Hauser R, Prins GS, Soto AM, et al. Endocrine-disrupting chemicals: An endocrine society scientific statement. Endocrine Reviews 2009, 30(4):293-342.
7. Foster WG Endocrine disruption and human reproductive effects: An overview. Water Quality Research Journal of Canada 2001, 36(2):253-271.
8. Ghuman J, Zunszain PA, Petitpas I, Bhattacharya AA, Otagiri M, Curry S Structural basis of the drug-binding specificity of human serum albumin. Journal of Molecular Biology 2005, 353:38-52.
9. Goodman JE, Witorsch RJ, McConnell EE, Sipes IG, Slayton TM, Yu CJ, et al. Weight-of-evidence evaluation of reproductive and developmental effects of low doses of bisphenol A. Critical Reviews in Toxicology 2009, 39:1-75.
10. He XM, Carter DC Atomic structure and chemistry of human serum albumin. Nature 1992, 358:209-215.
11. Hocman G Human thyroxine binding globulin (TBG), reviews of physiology. Biochemistry & Pharmacology 1981, 91:45-89.
12. Ishihara A, Sawatsubashi S, Yamauchi K Endocrine disrupting chemicals: interference of thyroid hormone binding to transthyretins and to thyroid hormone receptors. Molecular and Cellular Endocrinology 2003, 199:105-117.
13. Keri RA, Ho SM, Hunt PA, Knudsen KE, Soto AM, Prins GS An evaluation of evidence for the carcinogenic activity of bisphenol A. Reproductive Toxicology 2007, 24:240-252.
14. Kragh-Hansen U, Hellec F, Foresta BD, Maire ML, Moller JV Detergents as probes of hydrophobic binding cavities in serum albumin and other water-soluble proteins. Biophysical Journal 2001, 80:2898-2911.
15. Lans MC, Spiertz C, Brouwer A, Koeman JH Different competition of thyroxine binding to transthyretin and thyroxine-binding globulin by hydroxy-PCBs, PCDDs and PCDFs. European Journal of Pharmacology 1994, 270:129-136.
16. Loun B, Hage DS Characterization of thyroxine-albumin binding using high-performance affinity chromatography II. comparison of the binding of thyroxine, triiodothyronines and related compounds at the warfarin and indole sites of human serum albumin. Journal of Chromatography B 1995, 665:303-314.
17. Ma L Endocrine disruptors in female reproductive tract development and carcinogenesis. Trends in Endocrinology and Metabolism 2009, 20(7):357-363.
18. Marchesini GR, Meimaridou A, Haasnoot W, Meulenberg E, Albertus F, Mizuguchi M, et al. Biosensor discovery of thyroxine transport disrupting chemicals. Toxicology and Applied Pharmacology 2008, 232:150-160.
19. Meerts IATM, Zanden JJV, Luijks EAC, Leeuwen-Bol IV, Marsh G, Jakobsson E, et al. Potent competitive interactions of some brominated flame retardants and related compounds with human transthyretin in vitro. Toxicological Sciences 2000, 56:95-104.
20. Møller M, Denicola A Study of protein-ligand binding by fluorescence. Biochemistry and Molecular Biology Education 2002, 30(5):309-312.
21. Morais-de-Sa E, Pereira PJB, Saraiva MJ, Damas AM The crystal structure of transthyretin in complex with diethylstillbestrol. The Journal of Biological Chemistry 2004, 279(51):53483-53490.
22. Padmanabhan V, Siefert K, Ransom S, Johnson T, Pinkerton J, Anderson L, et al. Maternal bisphenol-A levels at delivery: a looming problem?. Journal of Perinatology 2008, 28(4):258-263.
23. Petersen CE, Ha CE, Jameson DM, Bhagavan NV Mutations in a specific human serum albumin thyroxine binding site define the structural basis of familial dysalbuminemic hyperthyroxinemia. The Journal of Biological Chemistry 1996, 271(32):19110-19117.
24. Richter CA, Birnbaum LS, Farabollini F, Newbold RR, Rubin BS, Talsness CE, et al. In vivo effects of bisphenol A in laboratory rodent studies. Reproductive Toxicology 2007, 24:199-224.
25. Somack R, Andrea TA, Jorgensen EC Thyroid hormone binding to human serum prealbumin and rat liver nuclear receptor: kinetics, contribution of the hormone phenolic hydroxyl group, and accommodation of hormone side-chain bulk. Biochemistry 1982, 21(1):163-170.
26. Staples CA, Dorn PB, Klecka GM, O'Block ST, Harris LR A review of the environmental fate, effects, and exposures of bisphenol-A. Chemosphere 1998, 36(10):2149-2173.
27. Sudlow G, Birkett DJ, Wade DN The characterization of two specific drug binding sites on human serum albumin. Molecular Pharmacology 1975, 11:824-832.
28. Thienpont LM, Uytfanghe KV, Marriot J, Stokes P, Siekmann L, Kessler A, et al. Metrologic traceability of total thyroxine measurements in human serum: efforts to establish a network of reference measurement laboratories. Clinical Chemistry 2005, 51(1):161-168.
29. Tsai WT Human health risk on environmental exposure to bisphenol-A: A review. Journal of Environmental Science and Health Part C 2006, 24:225-255.
30. Vandenberg LN, Maffini MV, Sonnenschein C, Rubin BS, Soto AM Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. Endocrine Reviews 2009, 30(1):75-95.
31. Vom Saal FS, Hughes C An extensive new literature concerning low-dose effects of bisphenol A shows the need for a new risk assessment. Environmental Health Perspectives 2005, 113(8):926-933.
32. Wu SP, Ding BL, Wu JB, Jiang ZQ Fluorescence quenching study on the interaction of bases of nucleic acid with electron-accepting sensitizer and serum albumin containing electron-rich tryptophan residue. Research on chemical intermediates 2000, 26(7-8):727-737.
33. Zhou A, Wei Z, Read RJ, Carrell RW Structural mechanism for the carriage and release of thyroxine in the blood. Proceedings of the National Academy of Sciences of the United States of America 2006, 103(36):13321-13326.
34. Zia H, Price JC Binding study of tetracyclines to human serum albumin using difference spectrophotometry. Journal of Pharmaceutical Sciences 1976, 65(2):226-230.